HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

Group A Streptococcal Infections

Group A Streptococcal Infections

Streptococcus pyogenes, the causative agent of Group A Streptococcal (GAS) infections, employs an array of virulence factors that contribute to its pathogenicity. Adhesins and surface proteins enable GAS to attach to host tissues, promoting colonization and evasion of the immune system. Additionally, streptolysins and other toxins facilitate tissue damage and immune evasion during infection. The M protein, a major surface protein of S. pyogenes, plays a crucial role in virulence and immune evasion. Variability in the M protein allows the bacterium to evade host immune responses, contributing to the persistence of GAS infections. Understanding the molecular mechanisms of GAS pathogenesis is essential for developing targeted therapeutic strategies and vaccines. Efforts to develop a vaccine against Streptococcus pyogenes face challenges due to the variability of the M protein and the potential for autoimmune reactions. Several vaccine candidates are in various stages of development, aiming to induce protective immune responses without triggering harmful side effects. These vaccines often target conserved regions of the bacterial cell wall or utilize modified M protein fragments to stimulate immune responses. The quest for an effective GAS vaccine involves a balance between addressing the bacterium's antigenic diversity and avoiding autoimmunity. Research continues to explore innovative approaches to overcome these challenges and provide a safe and broadly protective vaccine against Group A Streptococcal Infections.

Committee Members
Speaker at World Congress on Infectious Disease 2025 - Reza Nassiri

Reza Nassiri

Michigan State University, United States
Speaker at World Congress on Infectious Disease 2025 - Francis J Castellino

Francis J Castellino

University of Notre Dame, United States
Speaker at World Congress on Infectious Disease 2025 - Saurabh Chattopadhyay

Saurabh Chattopadhyay

University of Kentucky College of Medicine, United States
WCID 2025 Speakers
Speaker at World Congress on Infectious Disease 2025 - Johnson J H Wang

Johnson J H Wang

Wang Electro-Opto Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Victor J Alexander

Victor J Alexander

Capital Stem Cell Research Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Jacob R Miller

Jacob R Miller

Penn State University, United States
Speaker at World Congress on Infectious Disease 2025 - Anmol Grewal

Anmol Grewal

Abrazo Health, United States
Tags

Submit your abstract Today

Newsletter

By signing up, you agree to join our mailing list to receive information and updates.

Watsapp